OTC : MCRPF

MicroPort Scientific Corp.

$0.852 USD

$0 (0.0%)

Volume
0
Average Volume
321
Market Capitalization
$1.63B
P/E Ratio
35.62
Dividend Yield
0.00%
Price Target
Year High
$1.85
Year Low
$0.81
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$1.45
Company Overview

OTC

Jonathan W. Chen

Medical - Specialties

Healthcare

MCRPF

6547

CN

USD

https://www.microport.com

86 21 3895 4600

G60837104

N/A

Liquidity Metrics

1.63

1.45

1.14

0.60

0.00

Sales & Valuation

$996.38M

1.70

1.49

-41.64

-0.02

Profitability

$0.0152

$48.59M

4.89%

-23.39%

6.07%

1.32%

P/E Metrics

35.62

0.19

0.19

Analyst Price Target & Rating

N/A

0/5

0 Analysts

%

Financial Health Scores

0.46

4/9

$503.02M

$3.7B

$2.2B

-$128.21M

Key Metrics (TTM)

$2.61B

2.62

32.91

1.45

6.07%

-1.15%

3.34%

-2.40%

$0.63

313 days

Company Executives
Name Title
Lei Jiang Co-Chairperson & Chief Marketing Officer - China Executive Committee
Philippe Wanstok President of MicroPort CRM
He Li Board Secretary & Senior VP of Securities and Legal Affairs
Jie Zhang Chief Technology Officer
Hongbin Sun Chief Financial Officer
Jonathon W. Chen Rotating Chief Executive Officer
Zhaohua Chang Founder, Chairman, Chief Scientific Officer & Executive Director
Junder Chiang Chief Human Resources Officer
Tianbai Yu President of MicroPort Orthopedics China & Head of Global Supply Chain of Orthopedics
Yiyun Que EVice President of Intelligent Manufacturing & Global Supply Chain of MicroPort Sinica Co., Ltd.
Yimin Xu Senior EVice President of Regulatory Affairs & Property Management of MicroPort Sinica Co., Ltd
Poll Results

No votes yet today — be the first to share your view!

About MicroPort Scientific Corp. (OTC:MCRPF) Stock

MicroPort Scientific Corp. is an investment holding company, which engages in the research and development, manufacture, and distribution of medical devices. It operates through the following segments: Cardiovascular Devices Business, Orthopedics Devices Business, Cardiac Rhythm Management Business, Endovascular and Peripheral Vascular Devices Business, Neurovascular Devices Business, Surgical Devices Business, Heart Valve Business, Surgical Robot Devices Business, and Others. The Cardiovascular Devices Business segment offers integrated medical solutions for the treatment of coronary artery-related diseases, develops, manufactures, and commercializes coronary stents and related delivery systems, along with balloon catheters, passive accessories and active devices, in fulfilling the overal ... l demands of doctors and patients worldwide. The Orthopedics Devices Business segment is involved in the total solutions for the treatment of orthopedic problems, with an extensive range of orthopedics products that include reconstructive joints, spine and trauma products, and other professional implants and instruments. The Cardiac Rhythm Management Business segment develops, manufactures, and markets of products for the diagnosis, treatment, and management of heart rhythm disorders and heart failure, with products covering pacemakers, defibrillators, and cardiac resynchronization therapy devices. The Endovascular and Peripheral Vascular Devices Business segment focuses on providing integrated disease solutions for aortic and peripheral vascular diseases such as thoracic and abdominal aortic aneurysm, aortic dissection, atherosclerosis, and lower extremity arteriosclerotic occlusion. The Neurovascular Devices Business segment specializes in providing total solutions for the treatment of neurovascular diseases, including hemorrhagic stroke, cerebral atherosclerotic stenosis, and acute ischemic stroke, continuously focused on research and development, production and commercialization of neurovascular therapeutic and access devices. The Surgical Devices Business segment provides overall solutions for cardiac surgery and emergency life support. The Heart Valve Business segment includes sale, manufacture, research, and development of heart valve devices. The Surgical Robot Devices Business segment designs, develops, and commercializes innovative surgical robots. The company was founded by Zhao Hua Chang in 1998 and is headquartered in Shanghai, China.

Frequently Asked Questions

What is the current MicroPort Scientific Corp. (MCRPF) stock price?

MicroPort Scientific Corp.(OTC:MCRPF) stock price is $0.852 in the last trading session. During the trading session, MCRPF stock reached the peak price of $1.85 while $0.81 was the lowest point it dropped to. The percentage change in MCRPF stock occurred in the recent session was 0.0% while the dollar amount for the price change in MCRPF stock was $0.

MCRPF's industry and sector of operation?

The OTC listed MCRPF is part of Medical - Specialties industry that operates in the broader Healthcare sector.

Who are the executives of MCRPF?

Lei Jiang | Co-Chairperson & Chief Marketing Officer - China Executive Committee
Philippe Wanstok | President of MicroPort CRM
He Li | Board Secretary & Senior VP of Securities and Legal Affairs
Jie Zhang | Chief Technology Officer
Hongbin Sun | Chief Financial Officer

How many employees does MCRPF have?

Number of MCRPF employees currently stands at 6547. MCRPF operates from 1601 Zhangdong Road, Shanghai, SH 201203, CN.

Link for MCRPF official website?

Official Website of MCRPF is: https://www.microport.com

How do I contact MCRPF?

MCRPF could be contacted at phone #86 21 3895 4600 and can also be accessed through its website. MCRPF operates from 1601 Zhangdong Road, Shanghai, SH 201203, CN.

How many shares of MCRPF are traded daily?

The average number of MCRPF shares traded daily for last 3 months was 321.

What is the market cap of MCRPF currently?

The market value of MCRPF currently stands at $1.63B with its latest stock price at $0.852